x

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA)

Health Care/Life Sciences • Pharmaceuticals
CIK 1367083
Company

Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.

Address
5445 Conestoga Court
Suite 150
Boulder, Colorado 80301
Employees
172
Stock Info
Close
$2.1300
Day Range
2.0501 - 2.2500
52 Week Range
2.0200 - 9.3740
Average volume
115.52K
Short Interest
15.5K (02/14/25)
% of Float Shorted
0.97%
Market Cap
$3.44M
Revenue
$12.74M
Net Income
-$4.84M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$3.9334
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Amy M. Trombly
Lead Independent Director
John G. Mclaughlin
Independent Director
Philippe Weigerstorfer
Independent Director
Jay Edward Birnbaum
SEC filings
DateFormEvent
20 Dec, 2024 S-8
21 Nov, 2024 8-K
7 Nov, 2024 10-Q
22 Oct, 2024 8-K
20 Sep, 2024 424B5
20 Sep, 2024 8-K
28 Aug, 2024 8-K
23 Aug, 2024 8-K
23 Aug, 2024 424B5
21 Aug, 2024 8-K
15 Aug, 2024 DEFA14A
15 Aug, 2024 DEFA14A
8 Aug, 2024 10-Q
24 Jul, 2024 DEFA14A
1 Jul, 2024 DEF 14A
27 Jun, 2024 8-K
27 Jun, 2024 424B5
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 PRE 14A
21 Jun, 2024 4
21 Jun, 2024 4
17 Jun, 2024 10-K
17 Jun, 2024 S-8
9 Apr, 2024 8-K
2 Apr, 2024 8-K
22 Mar, 2024 8-K
8 Mar, 2024 8-K
8 Mar, 2024 424B3
8 Feb, 2024 10-Q
10 Jan, 2024 8-K
9 Jan, 2024 8-K
29 Dec, 2023 4
29 Dec, 2023 8-K
29 Dec, 2023 4
29 Dec, 2023 4
29 Dec, 2023 4
18 Dec, 2023 8-K
15 Dec, 2023 424B3
22 Nov, 2023 424B5
20 Nov, 2023 EFFECT
17 Nov, 2023 CORRESP
13 Nov, 2023 10-Q
7 Nov, 2023 UPLOAD
3 Nov, 2023 S-3
30 Oct, 2023 424B4
26 Oct, 2023 EFFECT
24 Oct, 2023 CORRESP
24 Oct, 2023 CORRESP
13 Oct, 2023 S-1/A
13 Oct, 2023 CORRESP
11 Oct, 2023 8-K
11 Oct, 2023 8-K/A
28 Sep, 2023 8-K
27 Sep, 2023 UPLOAD
19 Sep, 2023 S-1
15 Sep, 2023 DEFA14A
10 Aug, 2023 10-Q
27 Jul, 2023 DEF 14A
21 Jul, 2023 3
3 Jul, 2023 4
3 Jul, 2023 4
21 Jun, 2023 10-K
10 May, 2023 8-K
13 Apr, 2023 3
13 Apr, 2023 8-K
24 Feb, 2023 424B5
24 Feb, 2023 8-K
14 Feb, 2023 10-Q
31 Jan, 2023 8-K
6 Jan, 2023 8-K
30 Dec, 2022 4
30 Dec, 2022 4
30 Dec, 2022 4
30 Dec, 2022 4
30 Dec, 2022 4
30 Dec, 2022 8-K
30 Dec, 2022 4
23 Dec, 2022 424B3
23 Dec, 2022 8-K
14 Nov, 2022 10-Q
12 Oct, 2022 3
7 Oct, 2022 8-K
16 Sep, 2022 8-K
11 Aug, 2022 10-Q
22 Jul, 2022 8-K CEO Change
22 Jul, 2022 DEF 14A
13 Jul, 2022 10-K
29 Jun, 2022 NT 10-K
11 Feb, 2022 10-Q
20 Jan, 2022 8-K
14 Jan, 2022 4
14 Jan, 2022 8-K
14 Jan, 2022 4
14 Jan, 2022 4
14 Jan, 2022 4
14 Jan, 2022 4
14 Jan, 2022 4
13 Jan, 2022 S-8
6 Jan, 2022 8-K
15 Nov, 2021 10-Q
9 Nov, 2021 8-K
21 Sep, 2021 8-K
3 Sep, 2021 424B3
3 Sep, 2021 8-K
30 Aug, 2021 DEFA14A
23 Aug, 2021 DEFA14A
16 Aug, 2021 10-Q
16 Aug, 2021 DEFA14A
2 Aug, 2021 8-K
30 Jul, 2021 8-K
30 Jul, 2021 424B3
29 Jul, 2021 DEF 14A
20 Jul, 2021 8-K
14 Jul, 2021 10-K
9 Jul, 2021 8-K
6 Jul, 2021 8-K
29 Jun, 2021 NT 10-K
31 Mar, 2021 8-K
4 Mar, 2021 8-K
16 Feb, 2021 10-Q
13 Jan, 2021 4
11 Jan, 2021 8-K
8 Jan, 2021 4
8 Jan, 2021 4
8 Jan, 2021 8-K
18 Dec, 2020 CORRESP
15 Dec, 2020 CORRESP
7 Dec, 2020 UPLOAD
Last update:2025-03-06 12:47:52.219101
Sonoma Pharmaceuticals, Inc. by TradingView

Sign Up to Subscribe